News & Updates
Filter by Specialty:
Show Multimedia Only
No APHINITY between statin use and survival outcomes in early HER2-positive breast cancer
26 May 2025
byNatalia Reoutova
Statin use was not associated with improved survival outcomes in the phase III APHINITY trial investigating the addition of pertuzumab to trastuzumab and chemotherapy as adjuvant treatment for patients with early HER2-positive breast cancer (BC).
No APHINITY between statin use and survival outcomes in early HER2-positive breast cancer
26 May 2025
Full-spectrum microbiome drug for IBS with constipation clears phase II trial
25 May 2025
byJairia Dela Cruz
The next-generation oral full-spectrum microbiome drug EBX-102-02 appears to have an acceptable safety profile in patients with irritable bowel syndrome with constipation (IBS-C) while yielding improvements in symptom severity, abdominal pain, and stool consistency, according to the results of the phase IIa TrIuMPH* study.
